{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:35:58Z","timestamp":1773297358076,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0010626","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T20:43:11Z","timestamp":1273783391000},"page":"e10626","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG"],"prefix":"10.1371","volume":"5","author":[{"given":"Jasper G.","family":"van den Boorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther P. M.","family":"Tjin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy I.","family":"Picavet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico J.","family":"Meeuwenoord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri V.","family":"Filippov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P. Wietze","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan D.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J. M.","family":"Melief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie M.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases.","volume":"18","author":"JL Smith Jr","year":"1965","journal-title":"Cancer"},{"key":"ref2","first-page":"1259","article-title":"Influence of melanosome dynamics on melanoma drug sensitivity.","volume":"101","author":"KG Chen","year":"2009"},{"key":"ref3","first-page":"614","article-title":"Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.","volume":"40","author":"RS Bart","year":"1980","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.","volume":"14","author":"JM Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.161.5.1169","article-title":"Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.","volume":"161","author":"SA Rosenberg","year":"1985","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.","volume":"313","author":"SA Rosenberg","year":"1985","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1038\/jid.2008.101","article-title":"Immunotherapy for advanced melanoma.","volume":"128","author":"L Fang","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy.","volume":"8","author":"SA Rosenberg","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.coi.2005.01.011","article-title":"Breaking tolerance in cancer immunotherapy: time to ACT.","volume":"17","author":"WW Overwijk","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.181.1.776","article-title":"Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.","volume":"181","author":"S Adams","year":"2008","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.171.8.3941","article-title":"Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity.","volume":"171","author":"AS Lonsdorf","year":"2003","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/jid.2008.59","article-title":"Topical CpG enhances the response of murine malignant melanoma to dacarbazine.","volume":"128","author":"HM Najar","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.jid.5700777","article-title":"Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.","volume":"127","author":"P Redondo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref14","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.","volume":"52","author":"YA Sidky","year":"1992","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI23373","article-title":"Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.","volume":"115","author":"DE Speiser","year":"2005","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood.V89.8.2994","article-title":"Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.","volume":"89","author":"JE Wooldridge","year":"1997","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-4632.2005.02582.x","article-title":"Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.","volume":"44","author":"CM Ray","year":"2005","journal-title":"Int J Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1200\/JCO.2005.01.6816","article-title":"Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.","volume":"23","author":"RM Luiten","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref19","first-page":"709","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon.","volume":"354","author":"H Gogas","year":"2006"},{"key":"ref20","first-page":"409","article-title":"Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.","volume":"21","author":"P Quaglino","year":"2010"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\/occupational vitiligo.","volume":"17","author":"RE Boissy","year":"2004","journal-title":"Pigment Cell Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archderm.1970.04000080049010","article-title":"Depigmentation caused by phenolic detergent germicides.","volume":"102","author":"G Kahn","year":"1970","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1939.72800350003010a","article-title":"Occupational leukoderma.","volume":"113","author":"EA Oliver","year":"1939","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-0749.2006.00334.x","article-title":"Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.","volume":"19","author":"F Solano","year":"2006","journal-title":"Pigment Cell Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.1962.03050170011003","article-title":"Evaluation of monobenzone.","volume":"180","author":"SW Becker Jr","year":"1962","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2133.1953.tb13174.x","article-title":"A note on the depigmentary properties of monobenzylether of hydroquinone.","volume":"65","author":"L Forman","year":"1953","journal-title":"Br J Dermatol"},{"key":"ref27","first-page":"669","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.","volume":"97","author":"DB Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"ref28","first-page":"641","article-title":"Acquired leukomelanoderma caused by topical depigmenting agents.","volume":"109","author":"MF Grojean","year":"1982","journal-title":"Ann Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0536.1998.tb05863.x","article-title":"Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo.","volume":"39","author":"CC Lyon","year":"1998","journal-title":"Contact Dermatitis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1523-1747.ep12261579","article-title":"Biochemical basis for depigmentation of skin by phenolic germicides.","volume":"57","author":"J McGuire","year":"1971","journal-title":"J Invest Dermatol"},{"key":"ref31","article-title":"A Reactive ortho-Quinone Generated by Tyrosinase-Catalyzed Oxidation of the Skin Depigmenting Agent Monobenzone: Self-Coupling and Thiol-Conjugation Reactions and Possible Implications for Melanocyte Toxicity.","author":"P Manini","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00008390-199311000-00007","article-title":"In vivo depigmentation by hydroxybenzene derivatives.","volume":"3","author":"JM Menter","year":"1993","journal-title":"Melanoma Res"},{"key":"ref33","first-page":"447","article-title":"Depigmenting action of phenylhydroquinone, an O-phenylphenol metabolite, on the skin of JY-4 black guinea-pigs.","volume":"15","author":"K Tayama","year":"2002"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients.","author":"JG van den Boorn","year":"2009"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021927621813","article-title":"Intra-tumoral injection of CpG results in the inhibition of tumor growth in murine Colon-26 and B-16 tumors.","volume":"25","author":"S Sharma","year":"2003","journal-title":"Biotechnol Lett"},{"key":"ref36","first-page":"4165","article-title":"CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.","volume":"10","author":"T Switaj","year":"2004"},{"key":"ref37","first-page":"4072","article-title":"Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.","volume":"178","author":"B Berghofer","year":"2007"},{"key":"ref38","first-page":"1165","article-title":"Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.","volume":"118","author":"C Liu","year":"2008","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.4049\/jimmunol.176.8.4573","article-title":"Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.","volume":"176","author":"DH Schuurhuis","year":"2006","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08830180600743081","article-title":"T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity.","volume":"25","author":"JG van den Boorn","year":"2006","journal-title":"Int Rev Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1021\/tx00032a011","article-title":"Bihaptens with 5- and 6-methyl-substituted alkylcatechols and methylene lactone functional groups: tools for hapten (allergen or tolerogen)-protein interaction studies.","volume":"6","author":"A Nazih","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1073\/pnas.0809403105","article-title":"Immunostimulatory activity of haptenated proteins.","volume":"106","author":"NW Palm","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","article-title":"Monobenzyl Ether of Hydroquinone and 4-Tertiary Butyl Phenol Activate Markedly Different Physiological Responses in Melanocytes: Relevance to Skin Depigmentation.","author":"V Hariharan","year":"2009"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00002371-199801000-00003","article-title":"Comparative analysis of the in vivo expression of tyrosinase, MART-1\/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.","volume":"21","author":"JN Cormier","year":"1998","journal-title":"J Immunother"},{"key":"ref45","first-page":"934","article-title":"The hair follicle melanocytes in vitiligo in relation to disease duration.","volume":"23","author":"TS Anbar","year":"2009"},{"key":"ref46","first-page":"1077","article-title":"Evidence that the bulge region is a site of relative immune privilege in human hair follicles.","volume":"159","author":"KC Meyer","year":"2008"},{"key":"ref47","first-page":"25","article-title":"MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo.","volume":"111","author":"R Ruckert","year":"1998"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"21145","DOI":"10.1074\/jbc.M701705200","article-title":"Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.","volume":"282","author":"S Khan","year":"2007","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0010626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T16:38:01Z","timestamp":1591288681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0010626"}},"subtitle":[],"editor":[{"given":"Derya","family":"Unutmaz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0010626","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]}}}